Clinical Trial

Systemic Treatment Options for Generalized Lichen Planus

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2024 (before its estimated March 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Lichen planus is a chronic inflammatory skin condition with unknown etiology. It requires a long term treatment. Evaulating the most efficacious, safe and affordable treatment option is the need of the hour. This study is going to compare the efficacy of two familiar drugs (acitretin and methotrexate) in the treatment of generalized lichen planus as to find out the relatively more effective and safer treatment.
Trial Details
NCT Number NCT06739551
Lead Sponsor Sheikh Zayed Medical College
Conditions Lichen Planus
Enrollment 124 participants
Start Date 2024-12-10
Primary Completion 2025-03-15 (estimated)
Study Completion 2025-03-20 (estimated)
Updated on ClinicalTrials.gov 2024-12-18